TY - JOUR
T1 - Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients
AU - Breslavsky, A.
AU - Frand, J.
AU - Matas, Z.
AU - Boaz, M.
AU - Barnea, Z.
AU - Shargorodsky, M.
PY - 2013/12
Y1 - 2013/12
N2 - Background & aims: Vitamin D supplementation has the potential to alleviate the cardiovascular damage in diabetic patients. The present study was designed to evaluate long term impact of high doses of vitamin D on arterial properties, glucose homeostasis, adiponectin and leptin in patients with type 2 diabetes mellitus. Methods and results: In randomized, placebo-controlled study 47 diabetic patients were assigned into two groups: Group 1 received oral daily supplementation with vitamin D at a dose of 1000U/day for 12 months. Group 2 received matching placebo capsules. Blood sampling for metabolic parameters, including fasting glucose, lipid profile, HbA1C, insulin, hs-CRP, 25 OH Vit D, adiponectin and leptin was performed at baseline and at the end of the study. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR). Central aortic augmentation index (AI) was evaluated using SphygmoCor. Results: The two groups were similar at baseline in terms of hemodynamic parameters. After 12 months, AI decreased significantly during the treatment period in patients received vitamin D (p<0.0001) and did not change in placebo group. Glucose homeostasis parameters, leptin as well as leptin adiponectin ratio did not change in both groups. 25 OH Vit D level significantly increased (p=0.022) and circulating adiponectin marginally increased (p=0.065) during 12 month treatment period in active treatment and did not change in placebo group. Conclusions: High doses of vitamin D supplementation in diabetic patients was associated with significant decrease in AI during one year treatment. This beneficial vascular effect was not associated with improvement in glucose homeostasis parameters.
AB - Background & aims: Vitamin D supplementation has the potential to alleviate the cardiovascular damage in diabetic patients. The present study was designed to evaluate long term impact of high doses of vitamin D on arterial properties, glucose homeostasis, adiponectin and leptin in patients with type 2 diabetes mellitus. Methods and results: In randomized, placebo-controlled study 47 diabetic patients were assigned into two groups: Group 1 received oral daily supplementation with vitamin D at a dose of 1000U/day for 12 months. Group 2 received matching placebo capsules. Blood sampling for metabolic parameters, including fasting glucose, lipid profile, HbA1C, insulin, hs-CRP, 25 OH Vit D, adiponectin and leptin was performed at baseline and at the end of the study. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR). Central aortic augmentation index (AI) was evaluated using SphygmoCor. Results: The two groups were similar at baseline in terms of hemodynamic parameters. After 12 months, AI decreased significantly during the treatment period in patients received vitamin D (p<0.0001) and did not change in placebo group. Glucose homeostasis parameters, leptin as well as leptin adiponectin ratio did not change in both groups. 25 OH Vit D level significantly increased (p=0.022) and circulating adiponectin marginally increased (p=0.065) during 12 month treatment period in active treatment and did not change in placebo group. Conclusions: High doses of vitamin D supplementation in diabetic patients was associated with significant decrease in AI during one year treatment. This beneficial vascular effect was not associated with improvement in glucose homeostasis parameters.
KW - Arterial stiffness
KW - Circulating adiponectin
KW - Glucose homeostasis parameters
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84887623941&partnerID=8YFLogxK
U2 - 10.1016/j.clnu.2013.01.020
DO - 10.1016/j.clnu.2013.01.020
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23561637
AN - SCOPUS:84887623941
SN - 0261-5614
VL - 32
SP - 970
EP - 975
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 6
ER -